scorecard
  1. Home
  2. finance
  3. Wall Street's nightmare stock had a dream come true

Wall Street's nightmare stock had a dream come true

Linette Lopez   

Wall Street's nightmare stock had a dream come true

woman sun solar sunglasses glasses

Reuters

A woman watches a partial solar eclipse in Budapest March 20, 2015. A solar eclipse swept across the Atlantic Ocean on Friday with the moon set to block out the sun for about 2-1/2-hour, sky gazers in Europe, Africa and Asia getting a partial celestial show.

SunEdison, the solar manufacturing company that has been the bane of Wall Street's existence since it started crashing in July, is having a wonderful day.

That's rare these days.

The stock surged 36% in Thursday's trading day.

The reason why SunEdison surged is related to the reason it plummeted in the first place - SunEdison's attempt to acquire residential solar company, Vivint.

From Bloomberg:

Vivint shareholders led by Blackstone Group LP., which owned 77 percent of the shares at the start of the year, approved the $1.9 billion deal Wednesday, with more than 100 million votes in favor and 101,000 against.

SunEdison's shares took a nosedive when the Vivint deal was announced in July, because its terms revealed to investors that SunEdison was likely not as cash rich as they assumed. Additionally, the deal included "take or pay agreements" with TerraForm Power, SunEdison's yieldco - a sister company SunEdison created to manage its projects like a utility.

The take or pay agreement, which forces TerraForm Power to purchase certain Vivint assets, upset TerraForm Power shareholder, hedge fund manager David Tepper of Appaloosa Management. He doesn't think those assets are actually as valuable as SunEdison is making them out to be, so he's suing SunEdison over the deal.

And while SunEdison had a monster Thursday, it's still down 92% over the last year.

So this ain't over yet, people.

NOW WATCH: New York City rental prices are out of control

READ MORE ARTICLES ON



Popular Right Now



Advertisement